Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Factors Influencing Drug Absorption: Disease States and Pharmacology01:25

Factors Influencing Drug Absorption: Disease States and Pharmacology

599
Multiple disease states can significantly influence the oral drug absorption process by affecting blood flow and the functionality of the gastrointestinal (GI) system. Various GI diseases, including conditions that alter GI motility, such as diarrhea, decreased acid secretions (achlorhydria), and infections, have been associated with reduced drug absorption.
Substances such as alcohol and specific drugs, including antineoplastics, can also negatively impact drug absorption. For instance,...
599
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

13.7K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
13.7K
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

101
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
101
Mechanistic Models: Compartment Models in Individual and Population Analysis01:23

Mechanistic Models: Compartment Models in Individual and Population Analysis

68
Mechanistic models are utilized in individual analysis using single-source data, but imperfections arise due to data collection errors, preventing perfect prediction of observed data. The mathematical equation involves known values (Xi), observed concentrations (Ci), measurement errors (εi), model parameters (ϕj), and the related function (ƒi) for i number of values. Different least-squares metrics quantify differences between predicted and observed values. The ordinary least...
68
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

2.0K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

HyperPhS: a pharmacophore-guided multimodal representation framework for metabolic stability prediction through contrastive hypergraph learning.

Bioinformatics (Oxford, England)·2025
Same author

RetroCaptioner: beyond attention in end-to-end retrosynthesis transformer via contrastively captioned learnable graph representation.

Bioinformatics (Oxford, England)·2024
Same author

MTMol-GPT: De novo multi-target molecular generation with transformer-based generative adversarial imitation learning.

PLoS computational biology·2024
Same author

MVML-MPI: Multi-View Multi-Label Learning for Metabolic Pathway Inference.

Briefings in bioinformatics·2023
Same author

DeepBLI: A Transferable Multichannel Model for Detecting β-Lactamase-Inhibitor Interaction.

Journal of chemical information and modeling·2022
Same author

Microbe-bridged disease-metabolite associations identification by heterogeneous graph fusion.

Briefings in bioinformatics·2022
Same journal

circ2DGNN: circRNA-Disease Association Prediction via Transformer-Based Graph Neural Network.

IEEE/ACM transactions on computational biology and bioinformatics·2024
Same journal

Hierarchical Hypergraph Learning in Association- Weighted Heterogeneous Network for miRNA- Disease Association Identification.

IEEE/ACM transactions on computational biology and bioinformatics·2024
Same journal

Discriminative Domain Adaption Network for Simultaneously Removing Batch Effects and Annotating Cell Types in Single-Cell RNA-Seq.

IEEE/ACM transactions on computational biology and bioinformatics·2024
Same journal

MLW-BFECF: A Multi-Weighted Dynamic Cascade Forest Based on Bilinear Feature Extraction for Predicting the Stage of Kidney Renal Clear Cell Carcinoma on Multi-Modal Gene Data.

IEEE/ACM transactions on computational biology and bioinformatics·2024
Same journal

An End-to-End Knowledge Graph Fused Graph Neural Network for Accurate Protein-Protein Interactions Prediction.

IEEE/ACM transactions on computational biology and bioinformatics·2024
Same journal

Generative Biomedical Event Extraction With Constrained Decoding Strategy.

IEEE/ACM transactions on computational biology and bioinformatics·2024
See all related articles

Related Experiment Video

Updated: Jul 31, 2025

Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
08:51

Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts

Published on: September 20, 2024

1.4K

Low Rank Matrix Factorization Algorithm Based on Multi-Graph Regularization for Detecting Drug-Disease Association.

Chengwei Ai, Hongpeng Yang, Yijie Ding

    IEEE/ACM Transactions on Computational Biology and Bioinformatics
    |May 9, 2023
    PubMed
    Summary
    This summary is machine-generated.

    This study introduces a new computational method for predicting drug-disease associations. The novel approach utilizes multi-graph regularization with low-rank matrix decomposition, outperforming existing models in accuracy.

    More Related Videos

    A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports
    07:35

    A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports

    Published on: October 13, 2023

    1.7K
    Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers
    03:37

    Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers

    Published on: March 1, 2024

    815

    Related Experiment Videos

    Last Updated: Jul 31, 2025

    Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
    08:51

    Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts

    Published on: September 20, 2024

    1.4K
    A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports
    07:35

    A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports

    Published on: October 13, 2023

    1.7K
    Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers
    03:37

    Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers

    Published on: March 1, 2024

    815

    Area of Science:

    • Computational biology
    • Pharmacogenomics
    • Bioinformatics

    Background:

    • Predicting drug-disease associations is crucial for drug development.
    • Computational methods offer faster and more cost-effective alternatives to traditional approaches.
    • Existing methods require optimization for improved accuracy.

    Purpose of the Study:

    • To develop a novel similarity-based method for predicting drug-disease associations.
    • To enhance the accuracy and efficiency of computational drug-disease association prediction.
    • To investigate the impact of combining different similarity matrices.

    Main Methods:

    • Proposed a novel low-rank matrix decomposition method with multi-graph regularization.
    • Incorporated L2 regularization and combined various drug and disease similarity matrices.
    • Analyzed the contribution of different similarity information combinations.

    Main Results:

    • The proposed method demonstrated superior performance, particularly in AUPR (Area Under the Precision-Recall curve).
    • Combining only a subset of similarity information achieved desired performance, indicating efficiency.
    • Case studies confirmed the model's ability to predict potential disease-related drugs effectively.

    Conclusions:

    • The novel multi-graph regularization method offers a powerful tool for predicting drug-disease associations.
    • The findings suggest that selective use of similarity information can optimize prediction accuracy.
    • The model shows strong potential for real-world applications in drug discovery and development.